Haiyi Jiang - Chinese University of Hong Kong, Kinki University School of Medicine

基本信息

Career Trajectory

Bio

No content for now

Research Interests

Papers共 95 篇Author StatisticsCo-AuthorSimilar Experts

By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选

Durvalumab with or Without Tremelimumab in Combination with Chemotherapy in First-Line Metastatic NSCLC: Five-Year Overall Survival Outcomes from the Phase 3 POSEIDON Trial

Solange Peters,Byoung Chul Cho,Alexander V. Luft,Jorge Alatorre-Alexander,Sarayut Lucien Geater,Konstantin Laktionov,Dmytro Trukhin,Sang-We Kim, Grygorii M. Ursol,Maen Hussein,Farah Louise Lim,Cheng-Ta Yang,Luiz Henrique Araujo,Haruhiro Saito,Niels Reinmuth, Caitlin Lowery,Helen Mann,Ross Stewart,Haiyi Jiang,Edward B. Garon,Tony Mok, Melissa L. Johnson

JOURNAL OF THORACIC ONCOLOGYno. 1 (2025): 76-93

Cited1Views0WOSBibtex

Durvalumab in Combination with Chemoradiotherapy for Patients with Unresectable Stage III Non-Small-cell Lung Cancer: Results from the Phase 1 CLOVER Study

Dong-Wan Kim,Byoung Chul Cho, Krishna Pachipala,Sang-We Kim,Chih-Liang Wang,Gee -Chen Chang,Myung-Ju Ahn,Rosa Alvarez,Chao-Hua Chiu,Jose Trigo,Anna Estival,Sana D. Karam,Cathy O'Brien,Hema Gowda,Haiyi Jiang,Julie E. Bauman

Lung Cancer (2024): 107530-107530

Cited1Views0WOSBibtex

ADRIATIC: Durvalumab (D) As Consolidation Treatment (tx) for Patients (pts) with Limited-Stage Small-Cell Lung Cancer (LS-SCLC)

David R. Spigel,Ying Cheng,Byoung Chul Cho,Konstantin K. Laktionov,Jian Fang,Yuanbin Chen,Yoshitaka Zenke,Ki Hyeong Lee,Qiming Wang,Alejandro Navarro,Reyes Bernabe Caro, Eva Lotte Buchmeier,John W. C. Chang,Isamu Okamoto,Sema Sezgin Goksu,Andrzej Badzio,Bethany Gill,Hema Gowda,Haiyi Jiang,Suresh Senan

JOURNAL OF CLINICAL ONCOLOGYno. 17_SUPPL (2024)

Cited7Views0Bibtex

Author Statistics

Co-Author

Co-Institution

D-Core

合作者
学生
导师

No result temporarily, you can search similar Scholar with the same research interest

Data Disclaimer

The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn